Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Endogenous pentraxin 3 inhibits nephrocalcinosis and protects from hyperoxalluria-induced Chronic Kidney Disease

Julian A. Marschner, Shrikant R. Mulay, Stefanie Steiger, Lidia Anguiano, Antonio Inforzato, Cecilia Garlanda, Mantovani Alberto, Hans-Joachim Anders, “Endogenous pentraxin 3 inhibits nephrocalcinosis and protects from hyperoxalluria-induced Chronic Kidney Disease,” Klinikum der Universität München, Medizinische Klinik und Poliklinik IV, Nephrologisches Zentrum, Munich, Germany, Istituto Clinico Humanitas (ICH) IRCCS, Laboratory of Immunopharmacology, Rozzano, Italy, ERA-EDTA meeting Copenhagen 2018 SuO027.